Human herpesvirus 5, better known as cytomegalovirus (CMV), infects 50–90% of the adult
population worldwide and is the most common opportunistic infection in allogeneic …

Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality after
hematopoietic stem cell transplantation. Significant progress has been made in the …

Cytomegalovirus (CMV), like other herpesviruses, has the unique ability to establish latent
infection with subsequent reactivation during periods of stress and immunosuppression …

Despite the refinements in molecular methods for the detection of cytomegalovirus (CMV)
and the advent of highly effective preemptive strategies, CMV remains a leading cause of …

The past 1–2 years have seen major developments in the area of CMV management in
transplant recipients. Expanding diagnostic and therapeutic capabilities provide a …

Cytomegalovirus (CMV) is an opportunistic virus, whereby recipients are most susceptible
following allogeneic hematopoietic stem cell transplantation (allo‑HSCT). With the …

Human cytomegalovirus (CMV) infection and disease remains a significant cause of
morbidity and mortality for hematopoietic cell transplantation (HCT) recipients. Disruption of …

Background Cytomegalovirus (CMV) disease impacts morbidity and mortality in
hematopoietic cell transplant (HCT) recipients. This systematic review summarized data on …

With the rising number of patients undergoing hematopoietic stem cell transplantation
(HSCT), clinicians are more likely to encounter infectious complications in …

Introduction: Cytomegalovirus (CMV) still causes significant morbidity and mortality in
patients given allogeneic hematopoietic stem cell transplantation (HSCT). Despite effective …